AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-12.5 MG TAB

amlodipine besylate valsartan hydrochlorothiazide
$6.7762per EA

Strength

5; 12.5; 160 mg/1; mg/1; mg/1

NDC

64380019701

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA201087

On Market Since

6/27/2022

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines
Increased Diuresis
Thiazide Diuretic
Thiazides

Price History

1W

0.0%

1M

-2.8%

3M

-1.7%

6M

-0.8%

1Y

-6.1%

3Y

N/A

5Y

N/A

All

+8.3%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.